Global Stock News

A Low Valuation, High Growth Target: ANI Pharmaceuticals

Article feature image

A Low Valuation, High Growth Target: ANI Pharmaceuticals

AlexLMX/iStock via Getty Images
ANI Pharmaceuticals (ANIP) is a company I have owned off and on the last three months. The enterprise has made a number of small deals to acquire existing drugs patents, some production assets, and the potential for new pharma…

Click here to view the original article.

Share this article

Scroll to Top